X-154716212-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001081573.3(GAB3):c.190G>A(p.Glu64Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000223 in 1,211,631 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000062 ( 0 hom., 4 hem., cov: 23)
Exomes 𝑓: 0.000018 ( 0 hom. 8 hem. )
Consequence
GAB3
NM_001081573.3 missense
NM_001081573.3 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 3.74
Genes affected
GAB3 (HGNC:17515): (GRB2 associated binding protein 3) This gene is a member of the GRB2-associated binding protein gene family. These proteins are scaffolding/docking proteins that are involved in several growth factor and cytokine signaling pathways, and they contain a pleckstrin homology domain, and bind SHP2 tyrosine phosphatase and GRB2 adapter protein. The protein encoded by this gene facilitates macrophage differentiation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2846138).
BS2
High Hemizygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAB3 | NM_001081573.3 | c.190G>A | p.Glu64Lys | missense_variant | 2/10 | ENST00000424127.3 | NP_001075042.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAB3 | ENST00000424127.3 | c.190G>A | p.Glu64Lys | missense_variant | 2/10 | 1 | NM_001081573.3 | ENSP00000399588 | A2 | |
GAB3 | ENST00000369575.7 | c.190G>A | p.Glu64Lys | missense_variant | 2/10 | 1 | ENSP00000358588 | P4 | ||
GAB3 | ENST00000496390.5 | n.210G>A | non_coding_transcript_exon_variant | 2/9 | 1 | |||||
GAB3 | ENST00000369568.8 | c.190G>A | p.Glu64Lys | missense_variant | 2/9 | 2 | ENSP00000358581 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000617 AC: 7AN: 113541Hom.: 0 Cov.: 23 AF XY: 0.000112 AC XY: 4AN XY: 35671
GnomAD3 genomes
AF:
AC:
7
AN:
113541
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
35671
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000382 AC: 7AN: 183414Hom.: 0 AF XY: 0.0000590 AC XY: 4AN XY: 67852
GnomAD3 exomes
AF:
AC:
7
AN:
183414
Hom.:
AF XY:
AC XY:
4
AN XY:
67852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000182 AC: 20AN: 1098090Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 8AN XY: 363444
GnomAD4 exome
AF:
AC:
20
AN:
1098090
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
363444
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000617 AC: 7AN: 113541Hom.: 0 Cov.: 23 AF XY: 0.000112 AC XY: 4AN XY: 35671
GnomAD4 genome
AF:
AC:
7
AN:
113541
Hom.:
Cov.:
23
AF XY:
AC XY:
4
AN XY:
35671
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.190G>A (p.E64K) alteration is located in exon 2 (coding exon 2) of the GAB3 gene. This alteration results from a G to A substitution at nucleotide position 190, causing the glutamic acid (E) at amino acid position 64 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
D;.;.
Vest4
MVP
MPC
0.67
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at